The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
Biotech
The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
